Dobbelstein, Matthias

[["dc.bibliographiccitation.firstpage","688"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Biochemical and Biophysical Research Communications"],["dc.bibliographiccitation.lastpage","693"],["dc.bibliographiccitation.volume","331"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.contributor.author","Strano, Sabrina"],["dc.contributor.author","Roth, Judith"],["dc.contributor.author","Blandino, Giovanni"],["dc.date.accessioned","2022-03-01T11:44:47Z"],["dc.date.available","2022-03-01T11:44:47Z"],["dc.date.issued","2005"],["dc.identifier.doi","10.1016/j.bbrc.2005.03.155"],["dc.identifier.pii","S0006291X05006613"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/103119"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-531"],["dc.relation.issn","0006-291X"],["dc.title","p73-induced apoptosis: A question of compartments and cooperation"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","2101"],["dc.bibliographiccitation.issue","12"],["dc.bibliographiccitation.journal","Oncogene"],["dc.bibliographiccitation.lastpage","2106"],["dc.bibliographiccitation.volume","18"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.contributor.author","Wienzek, Sandra"],["dc.contributor.author","König, Claudia"],["dc.contributor.author","Roth, Judith"],["dc.date.accessioned","2022-03-01T11:46:06Z"],["dc.date.available","2022-03-01T11:46:06Z"],["dc.date.issued","1999"],["dc.identifier.doi","10.1038/sj.onc.1202512"],["dc.identifier.pii","BF1202512"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/103558"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-531"],["dc.relation.eissn","1476-5594"],["dc.relation.issn","0950-9232"],["dc.title","Inactivation of the p53-homologue p73 by the mdm2-oncoprotein"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","315"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Nature Genetics"],["dc.bibliographiccitation.lastpage","320"],["dc.bibliographiccitation.volume","30"],["dc.contributor.author","Contente, Ana"],["dc.contributor.author","Dittmer, Alexandra"],["dc.contributor.author","Koch, Manuela C."],["dc.contributor.author","Roth, Judith"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.date.accessioned","2022-03-01T11:45:52Z"],["dc.date.available","2022-03-01T11:45:52Z"],["dc.date.issued","2002"],["dc.identifier.doi","10.1038/ng836"],["dc.identifier.pii","BFng836z"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/103481"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-531"],["dc.relation.eissn","1546-1718"],["dc.relation.issn","1061-4036"],["dc.title","A polymorphic microsatellite that mediates induction of PIG3 by p53"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","439"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Molecular Medicine"],["dc.bibliographiccitation.lastpage","451"],["dc.bibliographiccitation.volume","2"],["dc.contributor.author","Elenbaas, Brian"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.contributor.author","Roth, Judith"],["dc.contributor.author","Shenk, Thomas"],["dc.contributor.author","Levine, Arnold J."],["dc.date.accessioned","2022-03-01T11:44:13Z"],["dc.date.available","2022-03-01T11:44:13Z"],["dc.date.issued","1996"],["dc.identifier.doi","10.1007/BF03401903"],["dc.identifier.pii","BF03401903"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/102965"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-531"],["dc.relation.eissn","1528-3658"],["dc.relation.issn","1076-1551"],["dc.title","The MDM2 Oncoprotein Binds Specifically to RNA through its RING Finger Domain"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","4715"],["dc.bibliographiccitation.issue","31"],["dc.bibliographiccitation.journal","Oncogene"],["dc.bibliographiccitation.lastpage","4727"],["dc.bibliographiccitation.volume","21"],["dc.contributor.author","Kartasheva, Natalia N"],["dc.contributor.author","Contente, Ana"],["dc.contributor.author","Lenz-Stöppler, Claudia"],["dc.contributor.author","Roth, Judith"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.date.accessioned","2022-03-01T11:46:06Z"],["dc.date.available","2022-03-01T11:46:06Z"],["dc.date.issued","2002"],["dc.identifier.doi","10.1038/sj.onc.1205584"],["dc.identifier.pii","BF1205584"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/103560"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-531"],["dc.relation.eissn","1476-5594"],["dc.relation.issn","0950-9232"],["dc.title","p53 induces the expression of its antagonist p73ΔN, establishing an autoregulatory feedback loop"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","8510"],["dc.bibliographiccitation.issue","11"],["dc.bibliographiccitation.journal","Journal of Virology"],["dc.bibliographiccitation.lastpage","8516"],["dc.bibliographiccitation.volume","72"],["dc.contributor.author","Roth, Judith"],["dc.contributor.author","König, Claudia"],["dc.contributor.author","Wienzek, Sandra"],["dc.contributor.author","Weigel, Silke"],["dc.contributor.author","Ristea, Susanne"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.date.accessioned","2022-03-01T11:47:21Z"],["dc.date.available","2022-03-01T11:47:21Z"],["dc.date.issued","1998"],["dc.description.abstract","ABSTRACT The adenovirus E1B 55-kDa and E4 34-kDa oncoproteins bind and inactivate the p53 tumor suppressor gene product, resulting in cell transformation. A recently discovered cellular protein, p73, shows extensive similarities to p53 in structure and function. Here we show that the simultaneous transient expression of E1B 55-kDa and E4 34-kDa proteins is sufficient to drastically shorten the intracellular half-life of p53, leading to strongly reduced steady-state p53 levels. Concomitantly, the E1B 55-kDa and E4 34-kDa proteins act synergistically to inactivate the transcriptional activity of p53. Mutational analysis suggests that physical interactions between the E1B 55-kDa protein and p53 and between the E1B 55-kDa and E4 34-kDa proteins are both required for p53 degradation. In contrast, the ability of p53 to interact with the cellular mdm2 oncoprotein or with its cognate DNA element appears to be dispensable for its destabilization by adenovirus gene products. The adenovirus E1B 55-kDa protein did not detectably interact with p73 and failed to inhibit p73-mediated transcription; also, the E1B 55-kDa and E4 34-kDa proteins did not promote p73 degradation. When five amino acids near the amino termini were exchanged at corresponding positions between p53 and p73, this rendered p53 resistant and p73 susceptible to complex formation and inactivation by the E1B 55-kDa protein. Our results suggest that while p53 inactivation is a central step in virus-induced tumor development, efficient transformation can occur without targeting p73."],["dc.description.abstract","ABSTRACT The adenovirus E1B 55-kDa and E4 34-kDa oncoproteins bind and inactivate the p53 tumor suppressor gene product, resulting in cell transformation. A recently discovered cellular protein, p73, shows extensive similarities to p53 in structure and function. Here we show that the simultaneous transient expression of E1B 55-kDa and E4 34-kDa proteins is sufficient to drastically shorten the intracellular half-life of p53, leading to strongly reduced steady-state p53 levels. Concomitantly, the E1B 55-kDa and E4 34-kDa proteins act synergistically to inactivate the transcriptional activity of p53. Mutational analysis suggests that physical interactions between the E1B 55-kDa protein and p53 and between the E1B 55-kDa and E4 34-kDa proteins are both required for p53 degradation. In contrast, the ability of p53 to interact with the cellular mdm2 oncoprotein or with its cognate DNA element appears to be dispensable for its destabilization by adenovirus gene products. The adenovirus E1B 55-kDa protein did not detectably interact with p73 and failed to inhibit p73-mediated transcription; also, the E1B 55-kDa and E4 34-kDa proteins did not promote p73 degradation. When five amino acids near the amino termini were exchanged at corresponding positions between p53 and p73, this rendered p53 resistant and p73 susceptible to complex formation and inactivation by the E1B 55-kDa protein. Our results suggest that while p53 inactivation is a central step in virus-induced tumor development, efficient transformation can occur without targeting p73."],["dc.identifier.doi","10.1128/JVI.72.11.8510-8516.1998"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/103998"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-531"],["dc.relation.eissn","1098-5514"],["dc.relation.issn","0022-538X"],["dc.title","Inactivation of p53 but Not p73 by Adenovirus Type 5 E1B 55-Kilodalton and E4 34-Kilodalton Oncoproteins"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","193"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Journal of Virology"],["dc.bibliographiccitation.lastpage","202"],["dc.bibliographiccitation.volume","74"],["dc.contributor.author","Wienzek, Sandra"],["dc.contributor.author","Roth, Judith"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.date.accessioned","2022-03-01T11:47:21Z"],["dc.date.available","2022-03-01T11:47:21Z"],["dc.date.issued","2000"],["dc.description.abstract","ABSTRACT The p53 tumor suppressor protein represents a target for viral and cellular oncoproteins, including adenovirus gene products. Recently, it was discovered that several proteins with structural and functional homologies to p53 exist in human cells. Two of them were termed p51 and p73. We have shown previously that the E1B 55-kDa protein (E1B-55 kDa) of adenovirus type 5 (Ad5) binds and inactivates p53 but not p73. Further, p53 is rapidly degraded in the presence of E1B-55 kDa and the E4orf6 protein of this virus. Here, it is demonstrated that p51 does not detectably associate with E1B-55 kDa. While p53 is relocalized to the cytoplasm by E1B-55 kDa, p51's location is unaffected. Finally, p51 retains its full transcriptional activity in the presence of E1B-55 kDa. Apparently, p51 does not represent a target of Ad5 E1B-55 kDa, suggesting that the functions of p51 are distinct from p53-like tumor suppression. E1B-55 kDa from highly oncogenic adenovirus type 12 (Ad12) was previously shown to surpass the oncogenic activity of Ad5 E1B-55 kDa in various assay systems, raising the possibility that Ad12 E1B-55 kDa might target a broader range of p53-like proteins. However, we show here that Ad12 E1B-55 kDa also inhibits p53's transcriptional activity without measurably affecting p73 or p51. Moderate inhibition of p51's transcriptional activity was observed in the presence of the E4orf6 proteins from Ad5 and Ad12. p53 and Ad12-E1B-55 kDa colocalize in the nucleus and also in cytoplasmic clusters when transiently coexpressed. Finally, E1B-55 kDa and E4orf6 of Ad12 mediate rapid degradation of p53 with an efficiency comparable to that of the Ad5 proteins in human and rodent cells. Our results suggest that E1B-55 kDa of either virus type has similar effects on p53 but does not affect p73 and p51."],["dc.description.abstract","ABSTRACT The p53 tumor suppressor protein represents a target for viral and cellular oncoproteins, including adenovirus gene products. Recently, it was discovered that several proteins with structural and functional homologies to p53 exist in human cells. Two of them were termed p51 and p73. We have shown previously that the E1B 55-kDa protein (E1B-55 kDa) of adenovirus type 5 (Ad5) binds and inactivates p53 but not p73. Further, p53 is rapidly degraded in the presence of E1B-55 kDa and the E4orf6 protein of this virus. Here, it is demonstrated that p51 does not detectably associate with E1B-55 kDa. While p53 is relocalized to the cytoplasm by E1B-55 kDa, p51's location is unaffected. Finally, p51 retains its full transcriptional activity in the presence of E1B-55 kDa. Apparently, p51 does not represent a target of Ad5 E1B-55 kDa, suggesting that the functions of p51 are distinct from p53-like tumor suppression. E1B-55 kDa from highly oncogenic adenovirus type 12 (Ad12) was previously shown to surpass the oncogenic activity of Ad5 E1B-55 kDa in various assay systems, raising the possibility that Ad12 E1B-55 kDa might target a broader range of p53-like proteins. However, we show here that Ad12 E1B-55 kDa also inhibits p53's transcriptional activity without measurably affecting p73 or p51. Moderate inhibition of p51's transcriptional activity was observed in the presence of the E4orf6 proteins from Ad5 and Ad12. p53 and Ad12-E1B-55 kDa colocalize in the nucleus and also in cytoplasmic clusters when transiently coexpressed. Finally, E1B-55 kDa and E4orf6 of Ad12 mediate rapid degradation of p53 with an efficiency comparable to that of the Ad5 proteins in human and rodent cells. Our results suggest that E1B-55 kDa of either virus type has similar effects on p53 but does not affect p73 and p51."],["dc.identifier.doi","10.1128/JVI.74.1.193-202.2000"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/103999"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-531"],["dc.relation.eissn","1098-5514"],["dc.relation.issn","0022-538X"],["dc.rights.uri","https://journals.asm.org/non-commercial-tdm-license"],["dc.title","E1B 55-Kilodalton Oncoproteins of Adenovirus Types 5 and 12 Inactivate and Relocalize p53, but Not p51 or p73, and Cooperate with E4orf6 Proteins To Destabilize p53"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","3251"],["dc.bibliographiccitation.issue","12"],["dc.bibliographiccitation.journal","Journal of General Virology"],["dc.bibliographiccitation.lastpage","3255"],["dc.bibliographiccitation.volume","80"],["dc.contributor.author","Roth, Judith"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.date.accessioned","2022-03-01T11:46:53Z"],["dc.date.available","2022-03-01T11:46:53Z"],["dc.date.issued","1999"],["dc.description.abstract","The p51/p63/KET proteins were identified based on their strong homology to the tumour suppressor p53 and a related set of proteins termed p73. All these protein species were shown to activate transcription from at least some p53-responsive promoters. To evaluate a possible role of the transcriptionally active splicing variant p51A/p63γ in tumour suppression, we determined whether viral oncoproteins that inactivate p53 might also target p51A. Neither the large T-antigen of simian vacuolating virus 40 (SV40) nor the E6 protein from human papillomavirus type 18 were found to inhibit p51A-mediated transcription, whereas they strongly suppress the activity of p53. Further, SV40 T-antigen directly interacts with p53 but not detectably with p51A. Finally, a cytoplasmic mutant (K128A) of SV40 T-antigen relocalizes p53 from the nucleus to the cytoplasm, but p51A remains in the nucleus when coexpressed with cytoplasmic T-antigen. These results strongly suggest that the inhibitory effect of these viral oncoproteins is specific for p53 and does not measurably affect p51A. Thus, unlike p53, p51A does not appear to be a necessary target in virus-induced cell transformation and may not exert a role comparable to p53 in tumour suppression."],["dc.description.abstract","The p51/p63/KET proteins were identified based on their strong homology to the tumour suppressor p53 and a related set of proteins termed p73. All these protein species were shown to activate transcription from at least some p53-responsive promoters. To evaluate a possible role of the transcriptionally active splicing variant p51A/p63γ in tumour suppression, we determined whether viral oncoproteins that inactivate p53 might also target p51A. Neither the large T-antigen of simian vacuolating virus 40 (SV40) nor the E6 protein from human papillomavirus type 18 were found to inhibit p51A-mediated transcription, whereas they strongly suppress the activity of p53. Further, SV40 T-antigen directly interacts with p53 but not detectably with p51A. Finally, a cytoplasmic mutant (K128A) of SV40 T-antigen relocalizes p53 from the nucleus to the cytoplasm, but p51A remains in the nucleus when coexpressed with cytoplasmic T-antigen. These results strongly suggest that the inhibitory effect of these viral oncoproteins is specific for p53 and does not measurably affect p51A. Thus, unlike p53, p51A does not appear to be a necessary target in virus-induced cell transformation and may not exert a role comparable to p53 in tumour suppression."],["dc.identifier.doi","10.1099/0022-1317-80-12-3251"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/103836"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-531"],["dc.relation.eissn","1465-2099"],["dc.relation.issn","0022-1317"],["dc.title","Failure of viral oncoproteins to target the p53-homologue p51A"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1834"],["dc.bibliographiccitation.issue","14"],["dc.bibliographiccitation.journal","Oncogene"],["dc.bibliographiccitation.lastpage","1842"],["dc.bibliographiccitation.volume","19"],["dc.contributor.author","Roth, Judith"],["dc.contributor.author","Koch, Philipp"],["dc.contributor.author","Contente, Ana"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.date.accessioned","2022-03-01T11:46:06Z"],["dc.date.available","2022-03-01T11:46:06Z"],["dc.date.issued","2000"],["dc.identifier.doi","10.1038/sj.onc.1203500"],["dc.identifier.pii","BF1203500"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/103559"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-531"],["dc.relation.eissn","1476-5594"],["dc.relation.issn","0950-9232"],["dc.title","Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","857"],["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","AIDS Research and Human Retroviruses"],["dc.bibliographiccitation.lastpage","865"],["dc.bibliographiccitation.volume","16"],["dc.contributor.author","Ristea, Susanne"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.contributor.author","Roth, Judith"],["dc.date.accessioned","2022-03-01T11:46:38Z"],["dc.date.available","2022-03-01T11:46:38Z"],["dc.date.issued","2000"],["dc.identifier.doi","10.1089/08892220050042792"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/103740"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-531"],["dc.relation.eissn","1931-8405"],["dc.relation.issn","0889-2229"],["dc.title","Rev Protein of Human Immunodeficiency Virus Type 1 and Cellular Exportin 1 Protein Relocalize Each Other to a Subnucleolar Structure"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]